← All decks

Dermatology

Pemphigus

Built from Dermatology, 5th Edition

The first 25 slides of Pemphigus
The first 25 slides, exactly as they appear. The full deck has 118 content slides.

What’s inside

11 sections · 118 slides

  1. 01

    Overview

    • What is pemphigus
    • How this topic is organised
    • Key features of pemphigus

    3 slides

  2. 02

    Classification, History, and Epidemiology

    The forms of pemphigus, how the disease was discovered, and who it affects

    • The three major forms of pemphigus
    • Classification of pemphigus
    • Classification of pemphigus
    • How pemphigus was discovered
    • Indirect immunofluorescence in pemphigus
    • Who gets pemphigus
    • Regional patterns in pemphigus subtype

    7 slides

  3. 03

    Fogo Selvagem

    An endemic form of pemphigus foliaceus in rural Brazil, and a natural experiment in how autoimmunity can be triggered

    • What is fogo selvagem
    • The insect-bite theory of fogo selvagem
    • A natural experiment in autoimmunity
    • From harmless antibody to disease-causing antibody

    4 slides

  4. 04

    Pathogenesis: Autoantibodies and Desmogleins

    How IgG antibodies against desmogleins actually pull skin cells apart

    • Pemphigus IgG causes blisters by itself
    • Desmogleins: the glue that pemphigus attacks
    • Cadherins: calcium-dependent cell glue
    • Two kinds of cell-cell junction in the skin
    • The desmoglein family and its partners
    • Proof that anti-desmoglein antibodies cause disease
    • The desmoglein compensation theory
    • Which antibody profile causes which disease
    • Why anti-Dsg1 alone spares the mucosa
    • Why anti-Dsg3 alone favours the mouth
    • Desmoglein compensation theory illustrated
    • Two more clues that support compensation theory
    • How the antibody actually breaks the glue

    13 slides

  5. 05

    Autoimmunity in Paraneoplastic Pemphigus

    A double attack - antibodies plus T cells - and the reference table of every known pemphigus target antigen

    • Two autoimmune attacks in paraneoplastic pemphigus
    • What T cells do in paraneoplastic pemphigus
    • Why patients start making these antibodies
    • Target antigens across the pemphigus family
    • Target antigens in pemphigus
    • Target antigens in pemphigus (continued)
    • Target antigens in pemphigus (continued)

    7 slides

  6. 06

    Clinical Features: Pemphigus Vulgaris

    Painful mouth erosions, fragile skin blisters, and the bedside signs that reveal fragile skin

    • Two subgroups of pemphigus vulgaris
    • Oral involvement in pemphigus vulgaris
    • Skin lesions of pemphigus vulgaris
    • What pemphigus vulgaris looks like on the skin
    • Unusual clinical presentations of pemphigus vulgaris
    • Unusual clinical presentations of pemphigus vulgaris
    • Bedside signs of fragile skin
    • Pemphigus vegetans
    • Pemphigus vegetans
    • Pemphigus vulgaris: flaccid blister and erosion

    10 slides

  7. 07

    Pemphigus Foliaceus and Its Variants

    A superficial, skin-only pattern of pemphigus, and the localized, endemic, herpetiform, and drug-induced variants built on it

    • What pemphigus foliaceus looks like
    • Pemphigus foliaceus: superficial erosions
    • Pemphigus foliaceus: erosions and thick scale-crusts
    • Pemphigus foliaceus of the scalp
    • Generalized pemphigus foliaceus
    • Pemphigus erythematosus (Senear-Usher syndrome)
    • Pemphigus erythematosus
    • Herpetiform pemphigus
    • Drug-induced pemphigus

    9 slides

  8. 08

    Paraneoplastic Pemphigus and IgA Pemphigus

    A tumour-associated, multi-organ disease, and a milder, pustular, IgA-driven form of pemphigus

    • The tumours behind paraneoplastic pemphigus
    • The hallmark of paraneoplastic pemphigus
    • Skin findings and complications of paraneoplastic pemphigus
    • Paraneoplastic pemphigus: fragile blisters
    • What is IgA pemphigus
    • What IgA pemphigus looks like
    • IgA pemphigus: sunflower-like pustule pattern
    • IgA pemphigus: targets and associations

    8 slides

  9. 09

    Pathology

    What a biopsy shows in each form of pemphigus, and how to take one correctly

    • How to biopsy a suspected pemphigus lesion
    • Preferred biopsy sites in autoimmune bullous disease
    • Pemphigus vulgaris: histology
    • Suprabasilar acantholysis in pemphigus vulgaris
    • Causes of eosinophilic spongiosis
    • Causes of eosinophilic spongiosis
    • Pemphigus foliaceus: histology
    • Pemphigus foliaceus: histopathologic features
    • Pemphigus foliaceus: cleavage within the granular layer
    • Pemphigus foliaceus: clefting in the upper spinous layer
    • Paraneoplastic pemphigus: histology
    • Paraneoplastic pemphigus: histopathologic features
    • IgA pemphigus: histology
    • IgA pemphigus: histopathologic features

    14 slides

  10. 10

    Diagnosis and Differential Diagnosis

    How pemphigus antibodies are actually detected, and the look-alike diseases each subtype must be told apart from

    • The gold standard: finding the autoantibody itself
    • Direct and indirect immunofluorescence techniques
    • What DIF and IIF actually show
    • Choosing the right IIF substrate
    • IIF for pemphigus and bullous pemphigoid - recommended substrates
    • Identifying the exact antigen: ELISA and beyond
    • How ELISA distinguishes the subtypes
    • ELISA target autoantigens across autoimmune bullous diseases
    • Differential diagnosis of pemphigus vulgaris
    • Differential diagnosis of pemphigus vegetans
    • Pemphigus vegetans - differential diagnosis
    • Differential diagnosis of pemphigus foliaceus
    • Differential diagnosis of paraneoplastic pemphigus
    • Disorders that crust the lips like paraneoplastic pemphigus
    • Disorders with hemorrhagic crusts of the vermilion lips
    • Hemorrhagic crusting of the vermilion lips
    • Differential diagnosis of IgA pemphigus

    17 slides

  11. 11

    Treatment

    From a once-fatal disease to a manageable one - corticosteroids, steroid-sparing agents, and modern B cell-targeted therapy

    • Why treatment must target antibody production
    • Systemic corticosteroids: the mainstay
    • Immunosuppressive steroid-sparing agents
    • Tapering and long-term strategy
    • Plasmapheresis and high-dose IVIg
    • Rituximab: B cell-depleting therapy
    • Emerging targeted therapies
    • The therapeutic ladder for pemphigus vulgaris
    • Therapeutic ladder for pemphigus vulgaris
    • Therapeutic ladder for pemphigus vulgaris (continued)
    • Treatment of pemphigus foliaceus
    • Treatment of paraneoplastic pemphigus
    • Treatment of IgA pemphigus
    • Summary: telling the pemphigus family apart
    • Key take-home points
    • References
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • Dermatology, 5th Edition (2-Volume Set)

    26 slides